2814

    0

    ARVEE

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    ARVEE LABORATORIES I LTD Share Price Today

    ARVEE LABORATORIES I LTD is currently trading at ₹164.9, up by ₹2.23 from the previous close. The stock touched an intraday high of ₹168.20 and a low of ₹163.20 during the latest trading session. Over the past one year, ARVEE LABORATORIES I LTD has delivered a loss of 16.77%, while the stock has gained 5.07% in the last one month.

    ARVEE LABORATORIES I LTD performance

    Today’s low Today’s high
    ₹ 163.20 ₹ 168.20
    ₹ 164.96
    52 week low 52 week high
    ₹ 129.11 ₹ 290.78
    ₹ 164.96
    Open Price ₹ 167.00
    Prev. Close ₹ 162.66
    Volume (Shares) 2328.00
    Total traded value ₹ 3.84
    Upper Circuit ₹ 195.19
    Lower Circuit ₹ 130.13
    info

    Investment Returns

    Over 1 Month 5.07% Over 3 Months 19.07% Over 6 Months -17.61% Over 1 Year -16.77%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    ARVEE LABORATORIES I LTD fundamentals


    • Market cap (Cr) 181.80
    • P/E Ratio (TTM) 72.03
    • Beta 1.11
    • Book Value / share 30.66
    • Return on equity 7.12%
    • EPS (TTM) 2.29
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 0.52
    info icon alternate text
    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) [-]
    info icon alternate text

    ARVEE LABORATORIES I LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 10.80
    Operating Expense 10.09
    Net Profit 0.52
    Net Profit Margin (%) 4.81
    Earnings Per Share (EPS) 0.47
    EBITDA 1.24
    Effective Tax Rate (%) 38.82
    Particulars DEC 2025 (Values in Cr)
    Revenue 9.78
    Operating Expense 8.53
    Net Profit 1.83
    Net Profit Margin (%) 18.71
    Earnings Per Share (EPS) 1.66
    EBITDA 1.76
    Effective Tax Rate (%) -30.93
    Particulars SEP 2025 (Values in Cr)
    Revenue 3.45
    Operating Expense 3.67
    Net Profit 0.01
    Net Profit Margin (%) 0.28
    Earnings Per Share (EPS) 0.01
    EBITDA 0.35
    Effective Tax Rate (%) 0.00
    Particulars JUN 2025 (Values in Cr)
    Revenue 7.48
    Operating Expense 7.47
    Net Profit 0.17
    Net Profit Margin (%) 2.27
    Earnings Per Share (EPS) 0.15
    EBITDA 0.50
    Effective Tax Rate (%) 5.88
    Particulars MAR 2025 (Values in Cr)
    Revenue 6.45
    Operating Expense 6.56
    Net Profit 0.07
    Net Profit Margin (%) 1.08
    Earnings Per Share (EPS) 0.06
    EBITDA 0.43
    Effective Tax Rate (%) 22.22
    Particulars MAR 2026 (Values in Cr)
    Revenue 31.51
    Operating Expense 29.76
    Net Profit 2.53
    Net Profit Margin (%) 8.02
    Earnings Per Share (EPS) 2.29
    EBITDA 3.87
    Effective Tax Rate (%) -4.11
    Particulars MAR 2025 (Values in Cr)
    Revenue 38.49
    Operating Expense 36.27
    Net Profit 2.15
    Net Profit Margin (%) 5.58
    Earnings Per Share (EPS) 1.95
    EBITDA 4.27
    Effective Tax Rate (%) 25.08
    Particulars MAR 2024 (Values in Cr)
    Revenue 30.35
    Operating Expense 29.10
    Net Profit 1.05
    Net Profit Margin (%) 3.45
    Earnings Per Share (EPS) 0.95
    EBITDA 3.58
    Effective Tax Rate (%) 42.62
    Particulars MAR 2023 (Values in Cr)
    Revenue 62.48
    Operating Expense 56.54
    Net Profit 4.12
    Net Profit Margin (%) 6.59
    Earnings Per Share (EPS) 3.74
    EBITDA 8.64
    Effective Tax Rate (%) 33.22
    Particulars MAR 2022 (Values in Cr)
    Revenue 40.33
    Operating Expense 37.33
    Net Profit 2.57
    Net Profit Margin (%) 6.37
    Earnings Per Share (EPS) 2.34
    EBITDA 6.13
    Effective Tax Rate (%) 25.50
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 28.37
    ROE % 7.12
    ROCE % 9.85
    Total Debt to Total Equity 0.03
    EBITDA Margin 11.09
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 26.42
    ROE % 3.67
    ROCE % 6.94
    Total Debt to Total Equity 0.04
    EBITDA Margin 11.80
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 25.46
    ROE % 15.85
    ROCE % 23.25
    Total Debt to Total Equity 0.08
    EBITDA Margin 14.08
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 21.73
    ROE % 11.33
    ROCE % 13.31
    Total Debt to Total Equity 0.26
    EBITDA Margin 15.22
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 19.45
    ROE % 13.33
    ROCE % 15.94
    Total Debt to Total Equity 0.32
    EBITDA Margin 13.99
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 4.90
    Total Assets 37.57
    Total Liabilities 37.57
    Total Equity 31.26
    Share Outstanding 1
    Price to Book Ratio 5.00
    Return on Assets (%) 5.71
    Return on Capital (%) 6.65
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 1.86
    Total Assets 38.19
    Total Liabilities 38.19
    Total Equity 29.11
    Share Outstanding 1
    Price to Book Ratio 5.43
    Return on Assets (%) 2.75
    Return on Capital (%) 3.49
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.89
    Total Assets 38.68
    Total Liabilities 38.68
    Total Equity 28.06
    Share Outstanding 1
    Price to Book Ratio 3.46
    Return on Assets (%) 10.64
    Return on Capital (%) 14.17
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 4.62
    Total Assets 38.68
    Total Liabilities 38.68
    Total Equity 23.94
    Share Outstanding 1
    Price to Book Ratio 5.23
    Return on Assets (%) 6.65
    Return on Capital (%) 9.51
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 6.60
    Total Assets 41.04
    Total Liabilities 41.04
    Total Equity 21.43
    Share Outstanding 1
    Price to Book Ratio 2.85
    Return on Assets (%) 6.52
    Return on Capital (%) 8.83
    Particulars MAR 2025 (Values in Cr)
    Net Income 2.87
    Cash from Operations 0.37
    Cash from Investing -1.31
    Cash from Financing -0.11
    Net change in Cash -1.63
    Free Cash Flow 2.23
    Particulars MAR 2024 (Values in Cr)
    Net Income 1.82
    Cash from Operations 4.09
    Cash from Investing -2.16
    Cash from Financing -0.18
    Net change in Cash 1.31
    Free Cash Flow 6.68
    Particulars MAR 2023 (Values in Cr)
    Net Income 6.16
    Cash from Operations 4.67
    Cash from Investing -1.25
    Cash from Financing -2.41
    Net change in Cash -0.74
    Free Cash Flow 6.16
    Particulars MAR 2022 (Values in Cr)
    Net Income 3.44
    Cash from Operations 1.62
    Cash from Investing 0.05
    Cash from Financing -6.06
    Net change in Cash -5.32
    Free Cash Flow 3.99
    Particulars MAR 2021 (Values in Cr)
    Net Income 3.64
    Cash from Operations 2.67
    Cash from Investing -0.60
    Cash from Financing 4.52
    Net change in Cash 5.62
    Free Cash Flow 4.96
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    ATUL LTD. 6521.60 28.32 3.08 19200.73 5563.00 7793.00
    BASF INDIA LTD 3660.50 38.07 4.00 15844.71 2906.90 5251.00
    ORIENTAL AROMATICS LIMITED 317.30 323.78 1.60 1067.83 227.05 421.60
    DEEPAK FERTILISERS & PETROCHEM 1650.95 28.27 3.04 20841.23 865.45 1776.95
    DEEPAK NITRITE LTD 1560.20 38.01 3.64 21280.04 1280.40 2006.65
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    ADVANCE PETROCHEMICALS LTD. 232.00 0.00 5.25 20.88 97.60 320.75
    ATUL LTD. 6521.60 32.27 3.17 19200.73 5563.00 7793.00
    BASF INDIA LTD 3660.50 38.00 3.98 15844.71 2906.90 5251.00
    ORIENTAL AROMATICS LIMITED 317.30 42.25 1.52 1067.83 227.05 421.60

    ARVEE LABORATORIES I LTD shareholding pattern

    Holding
    26.49%
    73.5%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    ARVEE LABORATORIES I LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    164.96 1.41 redarrow
    red-green-graph indicator
    9 Bearish
    7 Bullish
    • 5 Days 164.40
    • 26 Days 165.00
    • 10 Days 165.20
    • 50 Days 164.00
    • 12 Days 165.30
    • 100 Days 164.40
    • 20 Days 165.30
    • 200 Days 166.40
    163.21 PIVOT
    First Support 162.01 First Resistance 163.85 Second Support 161.37 Second Resistance 165.05 Third Support 160.17 Third Resistance 165.69
    RSI 49.95 ADX 65.43 MACD 0.27 Williams % R -75.20 Commodity Channel Index (CCI) -55.40
    Date 2026-07-03 Week 1347.00 Same Day 1034.00 Month 1819.00
    1 Year 1.12 3 Year 0.43
    Over 1 Month
    5.07% down
    Over 1 Year
    -16.77% down
    Over 3 Months
    19.07% down
    Over 3 Years
    11.65% down
    Over 6 Months
    -17.61% down
    Over 5 Years
    8.48% down

    ARVEE LABORATORIES I LTD Corporate Actions

    Ex-Date Ex-Bonus Ratio
    14 Oct 2020 13 Oct 2020 1:1

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Arvee Laboratories (India) Ltd?

    Answer Field

    Arvee Laboratories (India) Ltd share price is for NSE ₹ 164.90 & for BSE ₹ 0.00 as on Jul 03 2026 03:29 PM.

    What is the Market Cap of Arvee Laboratories (India) Ltd Share?

    Answer Field

    The market cap of Arvee Laboratories (India) Ltd for NSE ₹ 181.80 & for BSE ₹ 0.00 as on Jul 03 2026 03:29 PM.

    What is the 52 Week High and Low of Arvee Laboratories (India) Ltd?

    Answer Field

    The 52 Week High and Low of Arvee Laboratories (India) Ltd for NSE is ₹ 290.78 and ₹ 129.11 and for BSE is ₹ 0.00 and ₹ 0.00.

    What is 1 year return for Arvee Laboratories (India) Ltd?

    Answer Field

    The 1 year returns on the stock has been -16.77%.

    What is the P/E Ratio of Arvee Laboratories (India) Ltd Share?

    Answer Field

    As on Jul 03 2026 03:29 PM the price-to-earnings (PE) ratio for Arvee Laboratories (India) Ltd share is 72.03.

    What is the PB ratio of Arvee Laboratories (India) Ltd Share?

    Answer Field

    As on Jul 03 2026 03:29 PM, the price-to-book (PB) ratio for Arvee Laboratories (India) Ltd share is 30.66.

    How to Buy Arvee Laboratories (India) Ltd Share?

    Answer Field

    You can trade in Arvee Laboratories (India) Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Arvee Laboratories (India) Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Arvee Laboratories (India) Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Arvee Laboratories (India) Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |